Structural lung abnormalities in children and adults with cystic fibrosis after ETI using AI automated algorithms - Amsterdam 2025

Transformations in cystic fibrosis: from structural lung changes to systemic implications of modulator therapy

Chair(s): Bülent Taner Karadag, Tatjana Jakovska-Maretti

Session type: Oral presentation

Structural lung abnormalities in children and adults with cystic fibrosis after ETI using AI automated algorithms

Pranali Raut

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - AI-based mucus plug analysis to evaluate the effect of inhaled hypertonic saline in preschool children with CF: a randomized controlled trial

Harm Tiddens

Replay

Poster

Abstract

Slides

Lung Clearance Index trajectories in Australian children with Cystic Fibrosis

Tamara Blake

Replay

Abstract

Slides

Long-term non-pulmonary outcomes of Elaxacaftor-Tezacaftor-Ivacaftor (ETI) in pwCF

Andreas Jung

Replay

Poster

Abstract

Slides

Three-year adherence to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis

Carina M.e. Hansen

Replay

Poster

Abstract

Slides

CFTR modulators and MRSA in real-world practice: A three-group perspective

Ceren AyÇa Yildiz

Replay

Poster

Abstract

Slides

Feasibility of routine sputum induction in the era of Elexacaftor/Tezacaftor/Ivacaftor therapy: A real-world single-centre experience

Teresa Fuchs

Replay

Poster

Abstract

Slides

The interactions between respiratory viruses, the airway microbiome, and immune response during pulmonary exacerbations in young children with cystic fibrosis

Joke Bastiaenssen

Replay

Poster

Abstract

Slides

Structural lung abnormalities in children and adults with cystic fibrosis after ETI using AI automated algorithms

Pranali Raut

Replay

Poster

Abstract

Slides

Fetal Exposure and Lens-Related Ocular Changes Following In-Utero Administration of Elexacaftor/Tezacaftor/Ivacaftor in a Rat Model

Elena Schneider

Replay

Poster

Abstract

Slides

A comparison of cardiopulmonary exercise testing in children with cystic fibrosis in the pre and post modulator therapy era

Paul Burns

Replay

Poster

Abstract

Slides

Discussion and Q&A

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}